Income Statement

AUTONOMIX MEDICAL, INC.

AMIX

Performance Overview Click any row in the table to add it to this chart

in millions USD

Metric	Mar 31, 2025 2024 FY	Mar 31, 2024 2023 FY
Revenue	-	-
Cost of Revenue	-	-
Gross Profit	-	-
Operating Expenses	11.59	12.03
Research & Development	4.73	2.23
Selling, General & Administrative	6.86	5.25
Other Operating Expenses	-	-
Operating Income	-11.59	-12.03
Non-Operating Income	0.18	-3.40
Interest Income	0.35	0.13
Interest Expense	0.20	0.10
Other Non-Op Income / Expense	-	-
Income Before Tax	-11.41	-15.43
Income Tax Expense	0.00	0.00
Non-Controlling Interest	-	-
Net Income	-11.41	-15.43

Supplemental Per share data, derived & other items — not part of the income statement

in millions USD unless noted